Diabetic Foot Ulcers Treatment Market: Technologies and Global Markets

Diabetic foot ulcers is a common disease observed in diabetic patients. According to facts presented in fact sheet 2017, Center for Disease and Prevention, among the total diabetic population, 60%–80% suffers from foot ulcers. New and innovative treatments in wound dressings and therapy devices is expected to augment the diabetic foot ulcers treatment market growth. Since there are less availability of products to treat diabetic foot ulcers by device, provides a great opportunity for key players as well as new entrants to enter the diabetic foot ulcers treatment market. Furthermore, Negative pressure wound therapy devices essential for the management of diabetic foot ulcers, as also expected to favor the growth of diabetic foot ulcers treatment market.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1357

Diabetic foot ulcers treatment market is mainly driven by increasing prevalence of diabetes. According to World Health Organization, it was estimated that 422 million adults were suffering from diabetes, in 2014 globally. Furthermore, according to National Diabetes Statistics Report 2017, 30.3 million people in the U.S. have been estimated to have diabetes. This is expected to favor growth of the diabetic foot ulcers treatment market.

Furthermore, according to the data published by Agency for Healthcare Research & Quality (AHRQ) in October 2014, over 2.5 million individuals in the U.S. develop pressure ulcers annually, which costs the U.S. health care system around US$ 9.1 billion to US$ 11.6 billion per year

Increasing number of product launches and innovative therapies are also expected to drive the diabetic foot ulcers treatment market growth. For instance, in December 2017, FDA approved shockwave therapy by Dermapace for diabetic foot ulcers treatment. The FDA also approved a spray, Granulox by infirst Healthcare Ltd, in November 2017, for the treatment of diabetic foot ulcers.

The global diabetic foot ulcers treatment market was valued at US$ 1,209.4 million in 2017 and is expected to witness a robust CAGR of 29.4% over the forecast period (2017–2025).

Rising prevalence of diabetes is expected to favor growth of the diabetic foot ulcers treatment market in the near future

North America accounted for the largest share in the global diabetic foot ulcers treatment market, followed by Europe, in 2017. This is attributed to increasing prevalence of diabetes in North America. According to Center for Disease Control and Prevention, diabetes was the seventh leading cause of death in the U.S. in 2015 and 1.5 million new cases of diabetes were diagnosed among people aged 18 years and older.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1357

Furthermore, CDC partnered with various organizations to launch programs to create awareness about diabetes. For instance, CDC established National Diabetes Prevention Program in 2010, which provides a framework to prevent or delay type 2 diabetes efforts in the U.S., where this program is still active and effective.

In Asia Pacific region, the diabetic foot ulcers treatment market is expected to exhibit a high growth rate over the forecast period. This is owing to increasing number of population suffering from diabetes. For instance, according to The International Diabetes Federation, there were 382 million people with diabetes in 2013, of which over 60% of the people live in Asia, with almost half in China and India combined.

Some major players operating in the global diabetic foot ulcers treatment market include 3M Healthcare, Coloplast A/S, B.Braun Melsungen AG, Acelity L.P. Inc., Smith & Nephew Plc., Medtronic Plc, ConvaTec Inc, and Mölnlycke Health Care.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com/

This release was published on openPR.